|
931 |
A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot Study
Enthalten in Digital biomarkers Bd. 6, 2022, Nr. 1: 1-8. 8 S.
|
|
|
|
932 |
Can a Short-term Daily Oral Administration of Propolis Improve Muscle Fatigue and Recovery?
Enthalten in International journal of sports medicine 31.05.2022
|
|
|
|
933 |
Maternal and infant probiotic administration for morbidity of very low birth weight infants: a three-arm randomized placebo-controlled trial
Enthalten in European journal of nutrition 31.5.2022: 1-12
|
|
|
|
934 |
Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study
Enthalten in Journal of neurology 31.5.2022: 1-12
|
|
|
|
935 |
Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial
Enthalten in Osteoporosis international 24.5.2022: 1-8
|
|
|
|
936 |
New remote cerebral microbleeds in acute ischemic stroke: an analysis of the randomized, placebo-controlled WAKE-UP trial
Enthalten in Journal of neurology 19.5.2022: 1-8
|
|
|
|
937 |
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Enthalten in Neurotherapeutics 18.5.2022: 1-11
|
|
|
|
938 |
The Effects of Connective Tissue Manipulation in Primary Dysmenorrhea: a Randomized Placebo-Controlled Study
Enthalten in Reproductive sciences 13.5.2022: 1-11
|
|
|
|
939 |
ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria
Enthalten in Pediatric nephrology 12.5.2022: 1-13
|
|
|
|
940 |
Safety evaluation and biochemical efficacy of celery seed extract (Apium Graveolens) capsules in hypertensive patients: a randomized, triple-blind, placebo-controlled, cross-over, clinical trial
Enthalten in Inflammopharmacology 10.5.2022: 1-16
|
|
Administration
